We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Estimation of Haplotypes at DRD2 May Have Produced Misleading Results—Reply

Ke Xu, MD, PhD; Dirk Lichtermann, MD; Robert H. Lipsky, PhD; Petra Franke, MD; Xiehe Liu, MD; Ying Hu, PhD; Liping Cao, MD, PhD; Sibylle G. Schwab, PhD; Dieter B. Wildenauer, PhD; Claiton H. D. Bau, PhD; Erica Ferro, BS; Will Astor, BS; Thembi Finch, MS; Jeanietta Terry, BS; Julie Taubman, MS; Wolfgang Maier, MD; David Goldman, MD
Arch Gen Psychiatry. 2006;63(8):939-940. doi:10.1001/archpsyc.63.8.939-b.
Text Size: A A A
Published online


In reply

We reported the linkage of DRD2 haplotypes to heroin addiction in 799 Chinese and 663 German individuals.1 In both populations, linkage was driven by a large difference between cases and controls in frequencies of haplotypes that are uncommon. This led Curtis and Gurling to propose that the case-control differences are artifacts generated by the inability of MLOCUS (Jeffrey Long, PhD, University of Michigan, Ann Arbor), an expectation-maximization program, to accurately infer haplotypes. Genotyping error and population stratification are issues not raised in their letter but were potential problems of concern to us. The genotyping error rate was 0.02 in Chinese and 0.01 in German individuals, and there is no reason to think that error would cause cases and controls to differentiate. Stratification was not apparent with a 32-locus–single nucleotide polymorphism panel but a larger, more informative panel is now being applied.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...